RECENT EVIDENCE from several centers suggests that infarct size is an important determinant of prognosis in patients with acute myocardial infarction.1-3 Furthermore, it appears that infarct size is susceptible to favorable modification during early evolution of infarction.4 5 Accordingly, it is necessary to determine the extent to which ischemic myocardium has already become irreversibly damaged during the evolution of ischemic injury in order to assess the likelihood that therapeutic interventions designed to limit infarct size will be effective in a specific situation. Two classes of ischemic myocardium can be distinguished: blighted and jeopardized tissue. Blighted myocardium is tissue subjected to ischemia already sufficient to produce ultimate necrosis regardless of any subsequent intervention including reestablishment of blood flow. Jeopardized myocardium, on the other hand, may go on to suffer irreversible damage in the absence of a favorable intervention but is potentially salvageable if myocardial oxygen demand is reduced or oxygen supply increased. The need to differentiate the two is pressing. Patients may be benefited by coronary revascularization during the evolution of infarction only before the extent of blighted myocardium is maximum and when a significant portion of the heart is jeopardized. For example, reperfusion 30 sec after the onset of ischemia might well preclude infarction entirely by salvaging a large quantity of jeopardized myocardium; after 30 min it might diminish the extent of infarction; and after 30 hours it might not reduce infarct size at all since all previously jeopardized tissue may have become either blighted or frankly necrotic. Definitive answers regarding the value of coronary revascularization and other technics in limiting infarct size depend in part upon accurate assessment of: (1) the infarct size that would result ultimately if nothing were done to restore coronary blood flow (the sum of jeopardized plus blighted myocardium), and (2) the mass of myocardium that has already become blighted.
Since serum enzyme elevations, reflecting enzyme release from myocardium, are relied upon as indices of ischemic injury,6 one must consider the nature of myocardial enzyme changes in blighted and jeopardized tissue. Enzyme depletion in blighted myocardium may occur by at least two mechanisms including local denaturation in the heart and release of enzyme into the systemic circulation. If total enzyme activity in the heart is not altered by ischemia insufficient to produce cell death but is diminished consistently in cells irreversibly damaged, then the extent of enzyme depletion from the heart will be proportional to the quantity of blighted myocardium and hence ultimate infarct size.
Myocardial creatine phosphokinase (CPK) depletion following experimental coronary occlusion is proportional to infarct size and to the extent of reduction of regional myocardial blood flow. CPK activity is not altered in myocardium surrounding the infarct, and total myocardial CPK depletion correlates closely with infarct size 24 hours and 1 week after sustained coronary occlusion. In addition, myocardial CPK depletion can be determined accurately from analyses of serial serum CPK changes alone.7 An extensive body of data from a large number of centers supports the view that indeed blighted and/or frankly necrotic myocardium releases enzyme into the circulation. When one considers the question of whether jeopardized tissue releases enzyme, conclusions cannot be so certain. However, the large majority of patients with angina pectoris do not exhibit serum enzyme elevations temporally related to attacks. In addition, when infaret size is modified favorably in the conscious experimental animal by reperfusion commencing 5 hours after coronary occlusion, the amount of myocardium salvaged can be quantified by comparing serum CPK values projected with curve-fitting technics to serial changes actually observed, and salvage can be verified by myocardial analysis.8 Thus, in this setting, as well as in patients with transient myocardial ischemia, it appears that CPK is released from blighted myocardium only rather than jeopardized tissue subsequently salvaged by reperfusion.
The value of serum enzyme determinations in the diagnosis.of acute myocardial infarction is unequiv-*ocal. Availability of medical and surgical technics potentially capable of modifying infarct size in selected patients wi-th evolving infarction requires prompt quantitative assessment of: (1) necrosis already completed, (2) blighted tissue destined to undergo necrosis, and (3) jeopardized but potentially salvageable ischemic myocardium. In addition to their established,diagnostic value serum enzyme analyses are likely to prove useful in helping to make these important distinctions as well.
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